CMS proposes rule to slash Medicare 340B drug payments by over a third

CMS announced a proposed rule that would reduce the rates Medicare uses to reimburse hospitals for drugs purchased through the 340B program.

The reduction would be more than one-third, effectively reviving a similar policy that was introduced during the first Trump administration.

The change could lower hospital revenues from the 340B program and may affect patient access to discounted medicines, according to industry observers.